ALMR insider trading
NasdaqGS HealthcareAlamar Biosciences, Inc.: insider trade history from SEC Form 4 filings.
About Alamar Biosciences, Inc.
Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.
Company website: alamarbio.com
ALMR insider activity at a glance
FilingIQ tracks 46 insider transactions for ALMR in filings since Apr 20, 2026. The most recent transaction is dated Sep 14, 2026.
Across the full history, 2 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on ALMR insider trades is 66.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest ALMR Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading ALMR
Frequently asked
- How many insider trades does FilingIQ track for ALMR?
- FilingIQ tracks 46 Form 4 insider transactions for ALMR (Alamar Biosciences, Inc.), covering filings from Apr 20, 2026 onwards. 2 of those are dated within the last 90 days.
- Are ALMR insiders net buyers or net sellers?
- Across the full Form 4 history for ALMR, 2 transactions (4%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does ALMR insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is ALMR in?
- Alamar Biosciences, Inc. (ALMR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.46B.
Methodology & sources
Every ALMR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.